Tom Wilton
Corporate Officer/Principal en CARISMA THERAPEUTICS, INC. .
Cargos activos de Tom Wilton
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 | - |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Historial de carrera de Tom Wilton
Formación de Tom Wilton.
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Estados Unidos | 3 |
Operativa
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Tom Wilton
- Experiencia
